Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Diagnostic Histopathology is Scopus-indexed (Q4, CiteScore 0.9). It is covered by India's One Nation One Subscription scheme for reading access. Published by Elsevier Ltd.
Checked against the index lists dated .
ISSN 1756-2317Verify ISSN ↗1876-7621Verify ISSN ↗
Publisher: Elsevier Ltd
Cost to publish: About US$2,700 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pathology and Forensic Medicine | 162 / 209 | 22nd | Q4 |
| Histology | 52 / 62 | 16th | Q4 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2008–present, best quartile Q4, CiteScore 0.9.
Diagnostic Histopathology is Q4 in Pathology and Forensic Medicine (rank 162 of 209) and Q4 in Histology (rank 52 of 62), by CiteScore 2025.
Diagnostic Histopathology is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.9, quartile Q4, 22nd percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.237, quartile Q3, with an H-index of 31.
The publisher lists an article processing charge of about US$2,700 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Diagnostic Histopathology is published by Elsevier Ltd. Its print ISSN is 1756-2317 and its online ISSN is 1876-7621.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Diagnostic Histopathology has an h-index of 31 and a 2-year mean of 0.66 citations per paper (OpenAlex). Its Scopus CiteScore is 0.9, quartile Q4. On 2-year citations it ranks #136 of 208 Scopus journals in Pathology and Forensic Medicine.
Diagnostic Histopathology published 99 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 75 research articles (2025–2026), authors are most often from United Kingdom (50.7%), United States (18.7%) and Canada (4%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.